# Gain Therapeutics, Inc.: Form 8-K, filed Jun 14, 2024

- Company: [Gain Therapeutics, Inc.](/companies/ganx.md) (CIK 1819411)
- Form: 8-K
- Filed: 2024-06-14
- Accepted by EDGAR: Jun 14, 2024, 16:40 ET
- Period: 2024-06-13
- Accession: 0001104659-24-071801
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1819411/000110465924071801/tm2416858d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1819411/000110465924071801/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1819411/000110465924071801/tm2416858d2_8k.htm

Filed Jun 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-071801. Last ingested by Listed: Oct 30, 2026, 17:20 ET. No prices; not investment advice.